SUNITINIB MALATE AS MAINTENANCE THERAPY IN PATIENTS (PTS) WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II STUDY

被引：0
|
作者：
Blais, N. [1 ]
Page, R. [2 ]
Hainsworth, J. [3 ]
Soria, J. [4 ]
Laskin, J. [5 ]
Hamm, J. T. [6 ]
Selaru, P. [7 ]
Kim, S. T. [7 ]
Chao, R. [7 ]
Gervais, R. [8 ]
机构：
[1] CHUM Hop Notre Dame, Montreal, PQ, Canada
[2] Ctr Canc & Blood Disorders, Ft Worth, TX USA
[3] Sarah Cannon Res Inst, Nashville, TN USA
[4] Inst Gustave Roussy, Villejuif, France
[5] BC Canc Agcy, Vancouver, BC, Canada
[6] Norton Canc Inst, Louisville, KY USA
[7] Pfizer Inc, Global Res & Dev, La Jolla, CA USA
[8] Oncol Inst F Baclesse Ctr, Caen, France
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [31] A phase II study of vorinostat (NSC 701852) in patients (pts) with relapsed non-small cell lung cancer (NSCLC)
    Traynor, A. M.
    Dubey, S.
    Eickhoff, J.
    Kolesar, J. M.
    Marcotte, S. M.
    Hammes, L. C.
    Hallahan, C. M.
    Moore, C. E.
    Zwiebel, J.
    Schiller, J. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] Phase II study of danusertib (D) in advanced/metastatic non-small cell lung cancers (NSCLC).
    Gauler, Thomas Christoph
    Besse, Benjamin
    Novello, Silvia
    Smit, Egbert F.
    Plummer, Elizabeth R.
    Delord, Jean-Pierre
    Nicodemo, Maurizio
    Santoro, Armando
    Barone, Carlo
    Marchetti, Paolo
    Conte, Pier Franco
    De Jonge, Maja J.
    Awada, Ahmad
    Mariani, Mariangela
    Jannuzzo, Maria Gabriella
    Petroccione, Anna
    Ceruti, Roberta
    Davite, Cristina
    Eberhardt, Wilfried Ernst Erich
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [33] Phase II study of Crizotinib in East Asian patients (pts) with ROS1+ advanced non-small cell lung cancer (NSCLC)
    Goto, Koichi
    Yang, James C. H.
    Kim, Dong-Wan
    Lu, Shun
    Zhou, Jianying
    Seto, Takashi
    Yang, Jin-Ji
    Paolini, Jolanda
    Roychowdhury, Debasish
    Wu, Yi-Long
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] Phase II study of oxaliplatin and paclitaxel in advanced non-small cell lung cancer (NSCLC).
    Mauer, AM
    Otterson, G
    Rudin, CM
    Villalona, M
    Ansari, RH
    Szeto, L
    Vokes, EE
    CLINICAL CANCER RESEARCH, 2000, 6 : 4576S - 4576S
  • [35] Phase II study of paclitaxel and gemcitabine in advanced non-small cell lung cancer (NSCLC).
    Lazaro, M
    Jorge, M
    Castellanos, J
    ANNALS OF ONCOLOGY, 2000, 11 : 109 - 109
  • [36] A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancer
    Aerts, J. G. J. V.
    Surmont, V.
    van Klaveren, R. J.
    Tan, K. Y.
    Senan, S.
    van Wijhe, G.
    Vernhout, R.
    Verhoeven, G. T.
    Hoogsteden, H. C.
    van Meerbeeck, J. P.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (06) : 532 - 536
  • [37] Phase II study of carboplatin, irinotecan, and thalidomide in patients with advanced non-small cell lung cancer (NSCLC).
    Miller, AA
    Case, D
    Atkins, J
    Giguere, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 649S - 649S
  • [38] Neoadjuvant Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
    Nakagawa, Taku
    Minamiya, Yoshihiro
    Saito, Hajime
    Imai, Kazuhiro
    Konno, Hayato
    Kudo, Satoshi
    Saito, Yoshitaro
    Kurihara, Nobuyasu
    Watanabe, Shinnosuke
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S685 - S686
  • [39] Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea.
    Park, Keunchil
    Cho, Eun Kyung
    Kang, Jin Hyoung
    Han, Ji-Youn
    Lee, Jong Seok
    Kim, Dong-Wan
    Kim, Sang-We
    Cho, Byoung Chul
    Min, Young Joo
    Lee, Ki Hyeong
    Kim, Joo-Hang
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [40] Surgical operability of patients with locally advanced non-small cell lung cancer (NSCLC)
    Lardinois, Didier
    THERAPEUTISCHE UMSCHAU, 2012, 69 (07) : 411 - 419
12345